Sanofi is weighing a takeover bid for U.S. respiratory drugmaker Insmed

Summary
Insmed stock rose as much as 24% on Thursday, and any deal could be weeks away, according to Bloomberg
Description from Quartz.
Who is covering this
-
Sanofi is weighing a takeover bid for U.S. respiratory drugmaker Insmed
Insmed stock rose as much as 24% on Thursday, and any deal could be weeks away, according to Bloomberg
Comments
Comments need JavaScript.